1-3 of 3
Motonobu Watanabe
Close
Sort by
Journal Articles

The Bcr-Abl Kinase Inhibitor INNO-406 Induces Autophagy and Different Modes of Cell Death Execution in Bcr-Abl-Positive Leukemias.

Yuri Kamitsuji, MD, Junya Kuroda, PhD, Shinya Kimura, PhD, Ken-ichiro Watanabe, PhD, Eishi Ashihara, PhD, Yoshihiro Yui, MD, Motonobu Watanabe, MD, Hiroshi Matsubara, MD, Yasuhiro Mizushima, MD, Yoshimi Hiraumi, MD, Hideo Tanaka, PhD, Eri Kawata, MD, Taira Maekawa, MD, Tatsutoshi Nakahata, PhD, Souichi Adachi, PhD
Journal: Blood
Blood (2007) 110 (11): 2951.
https://doi.org/10.1182/blood.V110.11.2951.2951
Published: 2007
Journal Articles

The Significance of BAALC Expression and CEBPa Mutations as New Prognostic Factors in Pediatric Acute Myeloid Leukemia with Normal Karyotype.

Yasuhiro Mizushima, Souichi Adachi, Tomohiko Taki, Akira Shimada, Yasuhide Hayashi, Ichiro Tsukimoto, Masahiro Yui, Yuri Kamitsuji, Yoshimi Hiraumi, Hiroshi Matsubara, Motonobu Watanabe, Ken-ichiro Watanabe, Tatsutoshi Nakahata
Journal: Blood
Blood (2006) 108 (11): 2279.
https://doi.org/10.1182/blood.V108.11.2279.2279
Published: 2006
Journal Articles

Cell Death Mechanisms Induced by INNO-406, a Novel Tyrosine Kinase Inhibitor for Imatinib-Resistant Ph+ Leukemia.

Yuri Kamitsuji, MD, Souichi Adachi, MD, PhD, Motonobu Watanabe, MD, Hiroshi Matsubara, MD, Yasuhiro Mizushima, MD, Yoshimi Hiraumi, MD, Ken-Ichiro Watanabe, MD, PhD, Hideo Tanaka, MD, PhD, Junya Kuroda, MD, PhD, Eishi Ashihara, MD, PhD, Shinya Kimura, MD, PhD, Taira Maekawa, MD, Tatsutoshi Nakahata, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 2177.
https://doi.org/10.1182/blood.V108.11.2177.2177
Published: 2006